Public Opinion on Prescription Drugs and Their Prices
Many Americans face significant challenges affording their medications, including adults who take more medications or have lower incomes. KFF polling...
No More Injections? FDA Clears First Daily Pill for Moderate to Severe Psoriasis
For millions of people living with moderate-to-severe plaque psoriasis, the “gold standard” of treatment has long come with a literal...
Providence trims 2025 operating loss to $132M, notches Q4 gain
Providence made another substantial dent in its annual operating losses as it pared back non-core service, reduced its headcount and...
One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024
Editorial Note: This brief updates a previous analysis with more recent data, an evaluation of increases in concentration over time,...
Everyday PCOS Struggles, Finally Explained with TES
When you’re told you have polycystic ovary syndrome (PCOS), it sounds like a clear diagnosis. But living with PCOS is...
3 more drugs in the pipeline Optum says payers should watch
A new oral GLP-1 therapy and the first preventive option for COVID-19 are among the pipeline drugs that payers and...
The State of Patient Access 2026
At A Glance Experian Health’s latest State of Patient Access 2026 survey captures how patients and providers feel patient access...
LGBT People Experience Widespread Concerns and Challenges When it Comes to Health Care Affordability
Introduction Costs associated with health care and other household expenses weigh heavily on LGBT adults and health care affordability is...
OpenEvidence rolls out AI medical coding feature
OpenEvidence released an artificial intelligence-powered medical coding feature embedded in its clinical AI assistant. The new feature, called Coding Intelligence,...
What is patient access? Exploring the key benefits and challenges
At A Glance Experian Health’s State of Patient Access 2026 survey shows that timely access to care is the number...
